H. Yamaguchi, J.M. Hsu, W.H. Yang, M.C. Hung, Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat. Rev. Clin. Oncol. 19, 287–305 (2022). https://doi.org/10.1038/s41571-022-00601-9

Article  CAS  PubMed  Google Scholar 

P. Sharma, S. Hu-Lieskovan, J.A. Wargo, A. Ribas, Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 168, 707–723 (2017). https://doi.org/10.1016/j.cell.2017.01.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Dunn, S. Rao, Epigenetics and immunotherapy: the current state of play. Mol. Immunol. 87, 227–239 (2017). https://doi.org/10.1016/j.molimm.2017.04.012

Article  CAS  PubMed  Google Scholar 

S.J. Gallagher, E. Shklovskaya, P. Hersey, Epigenetic modulation in cancer immunotherapy. Curr. Opin. Pharmacol. 35, 48–56 (2017). https://doi.org/10.1016/j.coph.2017.05.006

Article  CAS  PubMed  Google Scholar 

S.J. Hogg, P.A. Beavis, M.A. Dawson, R.W. Johnstone, Targeting the epigenetic regulation of antitumour immunity. Nat. Rev. Drug Discov. 19, 776–800 (2020). https://doi.org/10.1038/s41573-020-0077-5

Article  CAS  PubMed  Google Scholar 

W. Sheng, M.W. LaFleur, T.H. Nguyen, S. Chen, A. Chakravarthy, J.R. Conway, Y. Li, H. Chen, H. Yang, P.H. Hsu, E.M. Van Allen, G.J. Freeman, D.D. De Carvalho, H.H. He, A.H. Sharpe, Y. Shi, LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell. 174, 549–563e519 (2018). https://doi.org/10.1016/j.cell.2018.05.052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Qin, S.N. Vasilatos, L. Chen, H. Wu, Z. Cao, Y. Fu, M. Huang, A.M. Vlad, B. Lu, S. Oesterreich, N.E. Davidson, Y. Huang, Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene. 38, 390–405 (2019). https://doi.org/10.1038/s41388-018-0451-5

Article  CAS  PubMed  Google Scholar 

Y. Liu, B. Debo, M. Li, Z. Shi, W. Sheng, Y. Shi, LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nat. Commun. 12, 6831 (2021). https://doi.org/10.1038/s41467-021-27179-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Tzelepis, H. Koike-Yusa, E. De Braekeleer, Y. Li, E. Metzakopian, O.M. Dovey, A. Mupo, V. Grinkevich, M. Li, M. Mazan, M. Gozdecka, S. Ohnishi, J. Cooper, M. Patel, T. McKerrell, B. Chen, A.F. Domingues, P. Gallipoli, S. Teichmann, H. Ponstingl, U. McDermott, J. Saez-Rodriguez, B.J.P. Huntly, F. Iorio, C. Pina, G.S. Vassiliou, K. Yusa, A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in Acute myeloid leukemia. Cell. Rep. 17, 1193–1205 (2016). https://doi.org/10.1016/j.celrep.2016.09.079

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Koike-Yusa, Y. Li, E.P. Tan, C. Velasco-Herrera Mdel, K. Yusa, Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267–273 (2014). https://doi.org/10.1038/nbt.2800

Article  CAS  PubMed  Google Scholar 

W. Li, H. Xu, T. Xiao, L. Cong, M.I. Love, F. Zhang, R.A. Irizarry, J.S. Liu, M. Brown, X.S. Liu, MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014). https://doi.org/10.1186/s13059-014-0554-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z. Miao, P. Moreno, N. Huang, I. Papatheodorou, A. Brazma, S.A. Teichmann, Putative cell type discovery from single-cell gene expression data. Nat. Methods. 17, 621–628 (2020). https://doi.org/10.1038/s41592-020-0825-9

Article  CAS  PubMed  Google Scholar 

J.N. Kochenderfer, Z. Yu, D. Frasheri, N.P. Restifo, S.A. Rosenberg, Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood. 116, 3875–3886 (2010). https://doi.org/10.1182/blood-2010-01-265041

Article  CAS  PubMed  PubMed Central  Google Scholar 

V.R. Juneja, K.A. McGuire, R.T. Manguso, M.W. LaFleur, N. Collins, W.N. Haining, G.J. Freeman, A.H. Sharpe, PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J. Exp. Med. 214, 895–904 (2017). https://doi.org/10.1084/jem.20160801

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Li, J.S.L. Yu, K. Tilgner, S.H. Ong, H. Koike-Yusa, K. Yusa, Genome-wide CRISPR-KO screen uncovers mTORC1-Mediated Gsk3 regulation in naive pluripotency maintenance and dissolution. Cell. Rep. 24, 489–502 (2018). https://doi.org/10.1016/j.celrep.2018.06.027

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.S.L. Yu, K. Yusa, Genome-wide CRISPR-Cas9 screening in mammalian cells. Methods. 164–165, 29–35 (2019). https://doi.org/10.1016/j.ymeth.2019.04.015

Article  CAS  PubMed  Google Scholar 

J.C. Scheuermann, A.G. de Ayala Alonso, K. Oktaba, N. Ly-Hartig, R.K. McGinty, S. Fraterman, M. Wilm, T.W. Muir, J. Muller, Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB. Nature. 465, 243–247 (2010). https://doi.org/10.1038/nature08966

Article  CAS  PubMed  PubMed Central  Google Scholar 

K.H. Ventii, N.S. Devi, K.L. Friedrich, T.A. Chernova, M. Tighiouart, E.G. Van Meir, K.D. Wilkinson, BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68, 6953–6962 (2008). https://doi.org/10.1158/0008-5472.CAN-08-0365

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.A. Suico, T. Shuto, H. Kai, Roles and regulations of the ETS transcription factor ELF4/MEF. J. Mol. Cell. Biol. 9, 168–177 (2017). https://doi.org/10.1093/jmcb/mjw051

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.A. Castro-Mondragon, R. Riudavets-Puig, I. Rauluseviciute, R.B. Lemma, L. Turchi, R. Blanc-Mathieu, J. Lucas, P. Boddie, A. Khan, N. Manosalva Perez, O. Fornes, T.Y. Leung, A. Aguirre, F. Hammal, D. Schmelter, D. Baranasic, B. Ballester, A. Sandelin, B. Lenhard, K. Vandepoele, W.W. Wasserman, F. Parcy, A. Mathelier, JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165–D173 (2022). https://doi.org/10.1093/nar/gkab1113

Article  CAS  PubMed  Google Scholar 

A. Garcia-Diaz, D.S. Shin, B.H. Moreno, J. Saco, H. Escuin-Ordinas, G.A. Rodriguez, J.M. Zaretsky, L. Sun, W. Hugo, X. Wang, G. Parisi, C.P. Saus, D.Y. Torrejon, T.G. Graeber, B. Comin-Anduix, S. Hu-Lieskovan, R. Damoiseaux, R.S. Lo, Ribas, Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell. Rep. 19, 1189–1201 (2017). https://doi.org/10.1016/j.celrep.2017.04.031

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Hildner, B.T. Edelson, W.E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B.U. Schraml, E.R. Unanue, M.S. Diamond, R.D. Schreiber, T.L. Murphy, K.M. Murphy, Batf3 deficiency reveals a critical role for CD8alpha + dendritic cells in cytotoxic T cell immunity. Science. 322, 1097–1100 (2008). https://doi.org/10.1126/science.1164206

Article  CAS  PubMed  PubMed Central  Google Scholar 

D.R. Peaper, P. Cresswell, Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell. Dev. Biol. 24, 343–368 (2008). https://doi.org/10.1146/annurev.cellbio.24.110707.175347

Article  CAS  PubMed  Google Scholar 

P. Golstein, G.M. Griffiths, An early history of T cell-mediated cytotoxicity. Nat. Rev. Immunol. 18, 527–535 (2018). https://doi.org/10.1038/s41577-018-0009-3

Article  CAS  PubMed